Anti-thymocyte globulin to prevent graft versus host disease after HLA matched related allogeneic hematopoietic cell transplantation in acute leukemia patients

被引：0
|
作者：
Yafour, N. [1 ]
Serradj, F. [1 ]
Osmani, S. [1 ]
Bouamama, F. [1 ]
Brahimi, M. [1 ]
Chekkal, M. [2 ]
Bouhafs, K. [1 ]
Baki, A. [1 ]
Arabi, A. [1 ]
Bouhass, R. [1 ]
Bekadja, M. A. [1 ]
机构：
[1] Univ Oran 1, Etab Hosp & Univ 1er Novembre 1954, Fac Med, Serv Hematol & Therapie Cellulaire, Oran, Algeria
[2] Etab Hosp & Univ 1er NOVEMBRE ORAN, Serv Hemobiol & Transfus Sanguine, Oran, Algeria
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P214
引用
收藏
页码：216 / 217
页数：2
相关论文
共 50 条
  • [31] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
    Ecsedi, Matyas
    Schmohl, Joerg
    Zeiser, Robert
    Drexler, Beatrice
    Halter, Jorg
    Medinger, Michael
    Duyster, Justus
    Kanz, Lothar
    Passweg, Jakob
    Finke, Juergen
    Bethge, Wolfgang
    Lengerke, Claudia
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1627 - 1636
  • [32] Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation
    Matyas Ecsedi
    Jörg Schmohl
    Robert Zeiser
    Beatrice Drexler
    Jörg Halter
    Michael Medinger
    Justus Duyster
    Lothar Kanz
    Jakob Passweg
    Jürgen Finke
    Wolfgang Bethge
    Claudia Lengerke
    Annals of Hematology, 2016, 95 : 1627 - 1636
  • [33] Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation
    Tandra, Anand
    Covut, Fahrettin
    Cooper, Brenda
    Creger, Richard
    Brister, Lauren
    McQuigg, Bernadette
    Caimi, Paolo
    Malek, Ehsan
    Tomlinson, Ben
    Lazarus, Hillard M.
    Otegbeye, Folashade
    Kolk, Merle
    de Lima, Marcos
    Metheny, Leland
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1644 - 1651
  • [34] Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
    H Khoury
    A Kashyap
    DR Adkins
    RA Brown
    G Miller
    R Vij
    P Westervelt
    K Trinkaus
    LT Goodnough
    RJ Hayashi
    P Parker
    SJ Forman
    JF DiPersio
    Bone Marrow Transplantation, 2001, 27 : 1059 - 1064
  • [35] Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
    Nagler, Arnon
    Kanate, Abraham S.
    Labopin, Myriam
    Ciceri, Fabio
    Angelucci, Emanuele
    Koc, Yener
    Gulbas, Zafer
    Arcese, William
    Tischer, Johanna
    Pioltelli, Pietro
    Ozdogu, Hakan
    Afanasyev, Boris
    Wu, Depei
    Arat, Mutlu
    Peric, Zinaida
    Giebel, Sebastian
    Savani, Bipin
    Mohty, Mohamad
    HAEMATOLOGICA, 2021, 106 (06) : 1591 - 1598
  • [36] Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia
    Ben Abdeljelil, Nour
    Ben Yaiche, Insaf
    Ouerghi, Rihab
    Torjemane, Lamia
    Belloumi, Dorra
    Turki, Ines
    Mekni, Sabrine
    Kanoun, Rimel Yousr
    Ben Othman, Tarek
    Ladeb, Saloua
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (08) : 527 - 538
  • [37] Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
    Waller, EK
    Langston, AA
    Lonial, S
    Chelly, J
    Somani, J
    Allen, AJ
    Rosenthal, H
    Redei, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (07) : 460 - 471
  • [38] Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
    Kim, Taeyun
    Choi, Yunsuk
    Lee, Je-Hwan
    Park, Silvia
    Ahn, Jae-Sook
    Moon, Joon-Ho
    Shin, Ho-Jin
    Lee, Won Sik
    Kim, Dajung
    Lee, Ho Sup
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (02): : 429 - 437
  • [39] Anti-thymocyte globulin induces higher response rates and less graft versus-host disease in multiple myeloma patients undergoing allogeneic stem cell transplantation
    Ayuk, Francis
    Perez-Simon, Jose A.
    Shimoni, Avichai
    Sureda, Anna
    Zabelina, Tatjana
    Schwerdtfeger, Rainer
    Martino, Rodrigo
    Sayer, Herbert G.
    Alegre, Adrian
    Lahuerta, Juan-Jose
    Atanackoyic, Djordje
    Wolschke, Christine
    Nagler, Arnon
    Zander, Axel R.
    Miguel, Jesus San
    Kroeger, Nicolaus
    BLOOD, 2007, 110 (11) : 875A - 875A
  • [40] In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors
    Kröger, N
    Zabelina, T
    Krüger, W
    Renges, H
    Stute, N
    Rischewski, J
    Sonnenberg, S
    Ayuk, F
    Tögel, F
    Schade, U
    Fiegel, H
    Erttmann, R
    Löliger, C
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 (08) : 683 - 689
12345